A just-released study from researchers at New York’s Memorial Sloan Kettering Cancer Center has revealed an alarming trend of diagnoses in patients under age 50, particularly among younger women with no self-reported history of asbestos exposure. The study’s authors urge physicians to familiarize themselves with the symptoms of the rare form of cancer and consider it as a diagnosis, even in patients who don’t fit the traditional demographic.
Mesothelioma Study Analyzes 273 Young Patients Treated Over 33 Years
The study, published March 18, 2026, in the journal JCO Precision Oncology, was a retrospective analysis of medical records and tissue samples from 273 patients diagnosed with diffuse pleural mesothelioma, all under the age of 50 and treated at MSK between 1990 and 2023.
The research revealed striking demographic shifts from the traditional mesothelioma patient profile. The number of females diagnosed and treated for mesothelioma was disproportionately higher than normally expected, and fewer patients reported a known asbestos exposure, especially those under age 35. Many of these younger mesothelioma patients had a family history of cancer, most commonly breast, lung, and colon cancer.
Reason for Mesothelioma in Younger Patients is Unclear
Researchers aren’t certain why they’re seeing more mesothelioma cases among young people, but note that in New York City, exposure to asbestos and other carcinogens after the September 11, 2001, World Trade Center collapse may play a role. Memorial Sloan Kettering Cancer Center thoracic medical oncologist Dr. Michael Offin commented, “As far as we know, we are the first hospital to report on the growing appreciation of mesothelioma in younger people.”
In addition to recognizing that they may start seeing younger patients with pleural mesothelioma, physicians treating this rare asbestos-related cancer need to familiarize themselves with the differences in how they should be treated. Treatments offered to mesothelioma patients in their 30s or 40s may differ dramatically from those for 70-year-olds. “In some patients, we may even suggest monitoring alone,” the study’s author explained, noting the disease can have long latency periods without advancement, allowing mesothelioma patients to delay treatment side effects.
If you or someone you love has been diagnosed with mesothelioma, the Patient Advocates at Mesothelioma.net are here to help. Contact us today at 1-800-692-8608 to learn more.
